Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world glucocorticoid use after benralizumab initiation in Japanese patients with EGPA
jRCT1030260163Recruiting
- Sponsor
- AstraZeneca
- Start
- Jul 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA), sponsored by AstraZeneca. Started Jul 2026; status: recruiting.
02
Drugs
benralizumab
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on jRCT1030260163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260163.